Recruiting

Chest Patch Sensor for Enhanced Sleep Apnea Evaluation

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This observational study aims to compare the accuracy of a chest patch sensor (C-TraQ) in measuring your respiratory rate, sleep position, and Apnea-Hypopnea Index (AHI) against traditional sleep study methods (Polysomnography).

What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Nervous System Diseases+9

+ Respiration Disorders

+ Respiratory Tract Diseases

Over 18 Years
+6 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Case-Only

Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.
Observational
Study Start: June 2026
See protocol details

Summary

Principal SponsorPranaQ Pte. Ltd.
Study ContactKe Wei Chen, M.D.More contacts
Last updated: August 4, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: June 5, 2026

Actual date on which the first participant was enrolled.

Disease Background Sleep apnea-hypopnea syndrome (SAHS) represents a pervasive and significant public health challenge, affecting a substantial segment of the adult population. Epidemiological data indicate that 34% of men and 17% of women between the ages of 30 and 70 are impacted by this condition. Despite its high prevalence, SAHS remains vastly underdiagnosed and consequently undertreated, leaving a large portion of the affected population vulnerable to its associated health risks. The established gold standard for the definitive diagnosis of sleep apnea is full-channel polysomnography (PSG). This comprehensive diagnostic procedure necessitates the simultaneous recording of a multitude of physiological and biological signals throughout the night, including electroencephalography (EEG) to monitor brain activity and sleep stages, electrooculography (EOG) for eye movements, electromyography (EMG) for muscle activity, and dedicated sensors for airflow, respiratory effort, and blood oxygen saturation. However, the clinical utility and accessibility of PSG are severely constrained by several inherent limitations. The study is highly uncomfortable, requiring patients to be affixed with a complex array of over 20 sensors and leads. Crucially, PSG is exclusively a hospital-based procedure, confining patients to an unfamiliar environment which can itself negatively impact natural sleep patterns (the "first-night effect"). Furthermore, the subsequent analysis of the multichannel PSG data is resource-intensive, demanding hours of expert technician time for the meticulous labeling and scoring of individual sleep breathing events, which contributes to its high cost, significant time commitment, and impracticality for widespread population screening or routine follow-up evaluation. These barriers highlight the urgent need for more accessible, less burdensome, and cost-effective diagnostic alternatives for sleep apnea. Description of PranaQ system The PranaQ system integrates multiple wearable sensors-one for the fingertip and one for the chest-with a mobile application and an interpretable AI platform. The sensors collect the following data: 1. T-TraQ (Fingertip Sensor): Records Photoplethysmography (PPG), accelerometer, and temperature data from the fingertip. 2. C-TraQ (Torso Patch Sensor): Also collects PPG, accelerometer, and temperature data. In this study, there are three sensors attached over sternum, abdomen and left subclavicle area. The PranaQ system, composed of wearable devices and cloud computing, is designed for both home and clinical settings to aid in the evaluation and diagnosis of suspected adult sleep apnea patients, as well as for long-term monitoring. Its function includes recording, storing, and exporting physiological waveforms. After the patient completes the recording, the collected signal data will be sent to the cloud for automatic report generation. The final sleep report will then be sent back to the healthcare provider through a browser-based user interface (PranaQ Expert Panel). Clinical Evaluation Objectives and Purpose 1. Validate the respiration information generated by the C-TraQ (Chest Patch Sensor). The raw signal from the chest patch is accelerometer-based. The respiration rate and waveform generated from the chest patch signal will be compared for consistency with information concurrently obtained from the thorax and abdominal belt collected through the PSG. 2. Validate the multi-sensor PranaQ system for the diagnosis of sleep apnea The TST, TRT, ODI, and AHI(both obstructive and central) generated by the PranaQ system will be compared with the results from PSG labeled by a technician.

Principal SponsorPranaQ Pte. Ltd.
Study ContactKe Wei Chen, M.D.More contacts
Last updated: August 4, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

180 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Case-only

These studies focus only on individuals who have a specific disease. Researchers examine patterns—often genetic or environmental—to uncover what might be linked to the condition.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Nervous System DiseasesRespiration DisordersRespiratory Tract DiseasesSigns and SymptomsSigns and Symptoms, RespiratorySleep Wake DisordersPathological Conditions, Signs and SymptomsSleep Disorders, IntrinsicDyssomniasApneaSleep Apnea SyndromesSleep Apnea, Central

Criteria

1 inclusion criteria required to participate
Subjects must be 18 years of age or older

5 exclusion criteria prevent from participating
Chronic Obstructive Lung Disease, Global Initiative for Chronic Obstructive

Devastating strokes, with a modified Rankin score (mRS) >= 4

Interstitial lung disease

Lung Disease (GOLD) categorization 3 or 4

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Taipei Veterans General Hospital

Taipei, TaiwanOpen Taipei Veterans General Hospital in Google Maps
Recruiting
One Study Center